Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum
Clinical trial NCT03072953 · TERMINATED
Trial details
- NCT number
- NCT03072953
- Sponsor
- Arena Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-07
- Primary completion
- 2018-05-22
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.